The past few years have been challenging for reproductive health in the United States. Significant legal changes, for example, around frozen embryos, have left many questioning the future of family building—especially for those who rely on assisted reproductive technologies (ART) like in vitro fertilization (IVF) to conceive. However, a powerful trend has emerged: Companies are expanding their family-building benefits.

Despite legal limitations, family-building benefits continue to trend upwards

Leading up to the Dobbs ruling, fertility and family-building benefits were already on the rise. 54% of large US employers covered IVF in 2022—up from 36% in 2015, reflecting the growing recognition of the diverse needs of today's workforce and the desire to attract and retain top talent. The increasing prevalence of delayed childbearing, rising infertility rates, and advancements in fertility treatments all contribute to the growing demand for these benefits. Despite 21 states restricting reproductive care, there has been a remarkable response from companies across the country. This proactive stance, even with potential legal limitations, underscores the immense value employers place on family-building benefits for their employees' family-building journeys. Companies understand that comprehensive family wellbeing benefits contribute to a happier, healthier, and more productive workforce.